MedPath

Early Procalcitonin Kinetics During Empirical Antibiotic Therapy in Critically Ill Patients

Completed
Conditions
Bacterial Infections
Registration Number
NCT02294695
Lead Sponsor
Domonkos Trásy
Brief Summary

To investigate the value of procalcitonin (PCT) kinetics between 0-8-16-24 hours after starting empirical antibiotic therapy in critically ill patients, to predict appropriate or inappropriate antibiotic treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
209
Inclusion Criteria
  • Clinical signs of infection
  • Suspected or proven acute infection requiring empiric antibiotic therapy as decided by the attending ICU physician
  • Suspected site of infection has to be present and documented
  • Microbiological sample sent for staining
  • Inflammatory markers available at the start of the therapy
Exclusion Criteria
  • Patients younger than 18 years
  • Who received prophylactic or empiric antibiotic therapy 48 hours before inclusion
  • Whose receiving acute renal replacement therapy in the first 24 hours following antibiotic treatment
  • Following cardiopulmonary resuscitation
  • End stage diseases with a "do not resuscitate" order
  • Immunocompromised patients (human immunodeficiency virus infection, bone marrow transplantation, malignant haematological disorders and chemotherapy)
  • Post cardiac surgery patients

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Procalcitonin kineticThe first six days after starting empiric antibiotic treatment

PCT levers are measured every 8 hours in the first day after starting empiric antibiotic treatment then daily and the changes in percentage are followed form the baseline value measured right before the first exposition of the antibiotic therapy.

Secondary Outcome Measures
NameTimeMethod
Sequential Organ Failure Assessment scoreThe first six days after starting empiric antibiotic treatment

SOFA score is measured every day after starting empiric antibiotic treatment.

Trial Locations

Locations (1)

Department of Anaesthesiology and Intensive Therapy

🇭🇺

Szeged, Csongrád, Hungary

© Copyright 2025. All Rights Reserved by MedPath